Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glial Tumor of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00540722
What this trial is testing

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT00006386
What this trial is testing

Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 80
Early research (Phase 1)Ended earlyNCT04963413
What this trial is testing

RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.

Who this might be right for
Glioblastoma
University of Florida 6
Large-scale testing (Phase 3)UnknownNCT00003788
What this trial is testing

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Colorado Health Foundation 270
Testing effectiveness (Phase 2)Ended earlyNCT03173950
What this trial is testing

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

Who this might be right for
MedulloblastomaEpendymomaPineal Region Tumors+2 more
National Cancer Institute (NCI) 136
Early research (Phase 1)Study completedNCT00006474
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Early research (Phase 1)Study completedNCT00005813
What this trial is testing

Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)Study completedNCT00961090
What this trial is testing

Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery

Who this might be right for
Glioblastoma
Matthew R Quigley 72
Testing effectiveness (Phase 2)Ended earlyNCT01517776
What this trial is testing

Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents

Who this might be right for
Gliomas
Martin-Luther-Universität Halle-Wittenberg 28
Early research (Phase 1)Looking for participantsNCT07390539
What this trial is testing

B7-H3.CD28Z.CART in CNS Neoplasms

Who this might be right for
Central Nervous System NeoplasmsBrain TumorBrain Tumor, Recurrent+11 more
Robbie Majzner 70
Not applicableLooking for participantsNCT05979064
What this trial is testing

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

Who this might be right for
GliomaGlioma, MalignantGlioblastoma+5 more
Northwell Health 10
Early research (Phase 1)Study completedNCT01222221
What this trial is testing

Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Cancer Research UK 45
Not applicableTemporarily pausedNCT05485038
What this trial is testing

General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas

Who this might be right for
Gliomas BenignGlioma, MalignantMetastases to Brain
Sklifosovsky Institute of Emergency Care 72
Early research (Phase 1)Looking for participantsNCT04185038
What this trial is testing

Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

Who this might be right for
Central Nervous System TumorDiffuse Intrinsic Pontine GliomaDiffuse Midline Glioma+8 more
Seattle Children's Hospital 90
Early research (Phase 1)Study completedNCT01644955
What this trial is testing

Carboplatin in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaRecurrent Adult Brain Tumor
James Elder 10
Very early researchStudy completedNCT02768389
What this trial is testing

Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma

Who this might be right for
GlioblastomaBrain Tumor
Case Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)WithdrawnNCT04406610
What this trial is testing

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

Who this might be right for
Glioma of BrainCAR-T Cell Immunotherapy
Fuda Cancer Hospital, Guangzhou
Testing effectiveness (Phase 2)Study completedNCT00006080
What this trial is testing

Fenretinide in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Study completedNCT00004259
What this trial is testing

Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 230
Testing effectiveness (Phase 2)Study completedNCT00003574
What this trial is testing

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Next Page